JP2022509445A5 - - Google Patents
Info
- Publication number
- JP2022509445A5 JP2022509445A5 JP2021547960A JP2021547960A JP2022509445A5 JP 2022509445 A5 JP2022509445 A5 JP 2022509445A5 JP 2021547960 A JP2021547960 A JP 2021547960A JP 2021547960 A JP2021547960 A JP 2021547960A JP 2022509445 A5 JP2022509445 A5 JP 2022509445A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- composition according
- pharmaceutical composition
- fibrosis
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024092192A JP2024133483A (ja) | 2018-10-25 | 2024-06-06 | 線維症を治療又は予防するための組成物及び方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2018-0128204 | 2018-10-25 | ||
| KR10-2018-0128033 | 2018-10-25 | ||
| KR1020180128033A KR102129178B1 (ko) | 2018-10-25 | 2018-10-25 | 심근경색 예방 또는 치료용 재조합 단백질을 포함하는 심근경색 예방 또는 치료용 조성물 |
| KR1020180128204A KR102129179B1 (ko) | 2018-10-25 | 2018-10-25 | 알츠하이머병 예방 또는 치료용 재조합 단백질을 포함하는 알츠하이머병 예방 또는 치료용 조성물 |
| KR1020180128625A KR102161892B1 (ko) | 2018-10-26 | 2018-10-26 | 특발성 폐섬유증 예방 또는 치료용 재조합 단백질을 포함하는 특발성 폐섬유증 예방 또는 치료용 조성물 |
| KR10-2018-0128625 | 2018-10-26 | ||
| PCT/IB2019/001136 WO2020084344A2 (en) | 2018-10-25 | 2019-10-24 | Compositions and methods for treating or preventing fibrosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024092192A Division JP2024133483A (ja) | 2018-10-25 | 2024-06-06 | 線維症を治療又は予防するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022509445A JP2022509445A (ja) | 2022-01-20 |
| JP2022509445A5 true JP2022509445A5 (https=) | 2022-10-27 |
| JP7659499B2 JP7659499B2 (ja) | 2025-04-09 |
Family
ID=70331794
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547960A Active JP7659499B2 (ja) | 2018-10-25 | 2019-10-24 | 線維症を治療又は予防するための組成物及び方法 |
| JP2024092192A Withdrawn JP2024133483A (ja) | 2018-10-25 | 2024-06-06 | 線維症を治療又は予防するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024092192A Withdrawn JP2024133483A (ja) | 2018-10-25 | 2024-06-06 | 線維症を治療又は予防するための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12139518B2 (https=) |
| EP (1) | EP3870210A4 (https=) |
| JP (2) | JP7659499B2 (https=) |
| CN (1) | CN113301914B (https=) |
| WO (1) | WO2020084344A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7659499B2 (ja) * | 2018-10-25 | 2025-04-09 | ネクセル カンパニー，リミテッド | 線維症を治療又は予防するための組成物及び方法 |
| MX2022002638A (es) | 2019-09-06 | 2022-03-25 | Novartis Ag | Proteinas de fusion terapeuticas. |
| KR102801198B1 (ko) * | 2021-06-28 | 2025-04-30 | (주) 넥셀 | 특발성 폐섬유증 예방 또는 치료용 폴리펩타이드 및 이를 포함하는 약학 조성물 |
| KR102758046B1 (ko) * | 2021-11-05 | 2025-01-23 | (주) 넥셀 | 궤양성 대장염 예방 또는 치료용 재조합 단백질 및 이를 포함하는 궤양성 대장염 예방 또는 치료용 조성물 |
| CN118633748A (zh) * | 2024-05-29 | 2024-09-13 | 哈尔滨工业大学 | 一种包含乳源mfg-e8的产品及其在改善衰老、学习和/或记忆障碍中的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972337A (en) | 1990-11-01 | 1999-10-26 | Cancer Research Fund Of Contra Costa | 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein |
| EP1004664A1 (en) | 1998-11-24 | 2000-05-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compositions and methods using lactadherin or variants thereof |
| IL160142A0 (en) * | 2001-08-17 | 2004-06-20 | Anosys Inc | Methods and compounds for the targeting of protein to exosomes |
| JP4160292B2 (ja) * | 2001-11-20 | 2008-10-01 | 独立行政法人科学技術振興機構 | 生体内のアポトーシス細胞の除去促進剤及び除去阻害剤 |
| WO2010096713A2 (en) * | 2009-02-20 | 2010-08-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method for the diagnosis of age-associated vascular disorders |
| JP2014507649A (ja) * | 2011-01-18 | 2014-03-27 | バクスター・インターナショナル・インコーポレイテッド | ヒト血液中の抗βアミロイド抗体の測定 |
| EP3021942A4 (en) * | 2013-07-19 | 2017-04-19 | The Regents of The University of California | Milk fat globule epidermal growth factor 8 regulates fatty acid uptake |
| WO2015025956A1 (ja) | 2013-08-22 | 2015-02-26 | 国立大学法人九州大学 | 心筋障害治療用薬剤組成物、心筋障害予防用薬剤組成物、心不全治療用薬剤組成物、心不全予防用薬剤組成物、心筋障害又は心不全を治療又は予防する方法、ｍｆｇ－ｅ８、ｍｆｇ－ｅ８の使用、及び心筋障害又は心不全を治療又は予防する化合物のスクリーニング方法 |
| AU2016260190A1 (en) | 2015-05-12 | 2017-11-23 | The Regents Of The University Of California | Peptide treatment for inflammation and fibrosis |
| KR20170013621A (ko) * | 2015-07-28 | 2017-02-07 | (주) 넥셀 | Ｍｉｌｋ ｆａｔ ｇｌｏｂｕｌｅ－ＥＧＦ ｆａｃｔｏｒ（ＭＦＧ－Ｅ８）을 이용한 조직섬유화 예방 또는 치료용 조성물 |
| CN105288592A (zh) | 2015-11-02 | 2016-02-03 | 哈尔滨博翱生物医药技术开发有限公司 | 成纤维细胞生长因子-21成熟肽在制备肝纤维化治疗药物中的应用 |
| GB2552473A (en) * | 2016-07-21 | 2018-01-31 | Evox Therapeutics Ltd | Surface decoration of extracellular vesicles |
| KR102129178B1 (ko) | 2018-10-25 | 2020-07-01 | (주) 넥셀 | 심근경색 예방 또는 치료용 재조합 단백질을 포함하는 심근경색 예방 또는 치료용 조성물 |
| KR102129179B1 (ko) | 2018-10-25 | 2020-07-01 | (주) 넥셀 | 알츠하이머병 예방 또는 치료용 재조합 단백질을 포함하는 알츠하이머병 예방 또는 치료용 조성물 |
| KR101947902B1 (ko) | 2017-05-17 | 2019-02-13 | (주) 넥셀 | 간 섬유화 예방 또는 치료용 재조합 단백질 및 이를 포함하는 간 섬유화 예방 또는 치료용 조성물 |
| KR102161892B1 (ko) | 2018-10-26 | 2020-10-05 | (주) 넥셀 | 특발성 폐섬유증 예방 또는 치료용 재조합 단백질을 포함하는 특발성 폐섬유증 예방 또는 치료용 조성물 |
| JP7659499B2 (ja) | 2018-10-25 | 2025-04-09 | ネクセル カンパニー，リミテッド | 線維症を治療又は予防するための組成物及び方法 |
| MX2022002638A (es) * | 2019-09-06 | 2022-03-25 | Novartis Ag | Proteinas de fusion terapeuticas. |
| CN118076371A (zh) | 2021-04-22 | 2024-05-24 | 百进生物科技公司 | 用于检测和耗竭磷脂酰丝氨酸阳性细胞的磷脂酰丝氨酸结合剂 |
| KR102758046B1 (ko) | 2021-11-05 | 2025-01-23 | (주) 넥셀 | 궤양성 대장염 예방 또는 치료용 재조합 단백질 및 이를 포함하는 궤양성 대장염 예방 또는 치료용 조성물 |
-
2019
- 2019-10-24 JP JP2021547960A patent/JP7659499B2/ja active Active
- 2019-10-24 WO PCT/IB2019/001136 patent/WO2020084344A2/en not_active Ceased
- 2019-10-24 EP EP19875681.9A patent/EP3870210A4/en active Pending
- 2019-10-24 CN CN201980086450.8A patent/CN113301914B/zh active Active
- 2019-10-24 US US17/285,040 patent/US12139518B2/en active Active
-
2024
- 2024-06-06 JP JP2024092192A patent/JP2024133483A/ja not_active Withdrawn
- 2024-10-24 US US18/925,356 patent/US20250115649A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022509445A5 (https=) | ||
| US9056892B2 (en) | Retrograde transport peptide and use of same for delivery to central nervous system | |
| US7045302B2 (en) | Expressed ligand-vascular intercellular signaling molecule | |
| US10864251B2 (en) | Peptides of syndecan-1 for inhibiting angiogenesis | |
| CA2914764C (en) | A biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis-and lymphangiogenesis-dependent diseases | |
| JP2005530484A5 (https=) | ||
| BRPI0821906B1 (pt) | Anticorpo isolado de comprimento total, seu uso, polinucleotideo, vetor, e célula hospedeira | |
| JPH11509187A (ja) | 内皮細胞増殖の調節 | |
| JP2016518325A5 (https=) | ||
| US20120231014A1 (en) | Neural Regeneration | |
| JP2022554267A (ja) | 組換えｃｄｋｌ５タンパク質、遺伝子療法、及び製造方法 | |
| PT98695A (pt) | Gene codificador do factor neurotrofico de ligacao a heparina | |
| JP2004099471A (ja) | 心筋梗塞および心不全の治療薬 | |
| CN100413888C (zh) | 可溶性多肽 | |
| US7408028B2 (en) | Peptides, antibodies thereto, and their use in treatment of central nervous system, damage | |
| ES2346185T3 (es) | Metodo para tratar el sistema nervioso central mediante la administracion de analogos estructurales de igf. | |
| US7029668B2 (en) | Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins | |
| JP2023509187A5 (https=) | ||
| CN116143950B (zh) | 一种抑制肿瘤侵袭转移的多肽组合及其应用 | |
| WO2023171577A1 (ja) | ニューロンの移動促進剤およびその利用 | |
| US20230390359A1 (en) | Use of reelin for treating cardiac diseases | |
| JP2020132575A (ja) | 血管新生促進剤 | |
| TW202547548A (zh) | 使用血腦屏障穿透性蛋白殼之ｔａｕ抑制子遞送 | |
| WO2026068747A1 (en) | Astrocytic phosphoprotein (pea-15) for use in the treatment and/or prevention of a neuronal disorder | |
| TW202320836A (zh) | 缺血性疾病之治療劑 |